Skip to main navigation Skip to search Skip to main content

Atopic dermatitis

  • Joerg Buddenkotte
  • , Fareed Ahmad
  • , Jui Wen Chang
  • , Sara Al-Khawaga
  • , Fang Wang
  • , Jianghui Meng
  • , Martin Steinhoff
  • Hamad Medical Corporation
  • Southern Medical University
  • Dublin City University
  • Qatar University
  • Cornell University
  • HBKU College of Health and Life Sciences

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disorder. Genetic as well as environmental factors contribute to AD, which is also part of the systemic atopy syndrome. Knowledge about the pathophysiology is still incomplete; however, it is evident that dysregulated innate and adaptive immunity, skin barrier function, and neuroimmune system, including pruritus, all contribute to the initiation, aggravation, and/or perpetuation of AD affecting mainly children and adolescents, but still adults with a significant impairment in patients' and families’ quality of life. The signs and symptoms can vary among individuals and in different genetic populations, albeit clinical characteristics like pruritus and location are largely common. Exciting new research has led to the development of new topical and systemic therapies against inflammation, skin barrier dysfunction, neuroimmune dysbalance, and pruritus. More treatments are currently in development and will be discussed here as well.

Original languageEnglish
Title of host publicationThe Itch Spectrum
PublisherElsevier
Pages285-307
Number of pages23
ISBN (Electronic)9780443341724
ISBN (Print)9780443341731
DOIs
Publication statusPublished - 25 Mar 2026

Keywords

  • Atopic dermatitis
  • Cytokines
  • Dupilumab
  • Jak inhibitors
  • Neuropeptides
  • Skin barrier
  • T cells
  • Therapy

Fingerprint

Dive into the research topics of 'Atopic dermatitis'. Together they form a unique fingerprint.

Cite this